Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Glioma × Restraint, Physical × Clear all

Phase

Phase NA 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Oligodendroglioma 1 Glioma 1 Glioblastoma 1 Astrocytoma 1

Interventions

trametinib 2 dabrafenib 2 perampanel 1 olutasidenib 1 Valproic Acid 1 Temozolomide 1 Restraint, Physical 1 Outcome Assessment, Health Care 1 Observational Studies as Topic 1 Levetiracetam 1 Cytochrome P-450 CYP3A 1 Cytochrome P-450 CYP2C9 1 Cytochrome P-450 CYP2C8 1 Cytochrome P-450 CYP2C19 1 Cytochrome P-450 CYP2B6 1 Cytochrome P-450 CYP1A2 1 Anticonvulsants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06625047 2025-12-31

Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

Mayo Clinic

Phase 4 Completed

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡